|Awarded On||August 19, 2020|
|Title||The Combinatorial Drug Discovery Program (CDDP)|
|Award Mechanism||Core Facility Support Awards|
|Institution/Organization||Texas A&M University System Health Science Center|
|Principal Investigator/Program Director||Peter Davies|
|Cancer Sites||All Sites|
*Pending contract negotiation
Finding new ways to use old drugs to treat cancer is one of the most effective ways to accelerate the discovery of new therapies that benefit patients with cancer. The CPRIT-funded Gulf Coast Consortium (GCC) Combinatorial Drug Discovery Program (CDDP) is a multi-institutional core facility that provides key resources to support cancer-related drug repurposing and combinatorial drug discovery research. The CDDP is a member of a network of collaborating core facilities, organized by GCC, to promote resource sharing and the elimination of wasteful duplication while providing researchers with the access to the sophisticated technologies necessary to support drug discovery research. In the last ...